1. Home
  2. CARM vs FBGL Comparison

CARM vs FBGL Comparison

Compare CARM & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • FBGL
  • Stock Information
  • Founded
  • CARM 2016
  • FBGL 1996
  • Country
  • CARM United States
  • FBGL Singapore
  • Employees
  • CARM N/A
  • FBGL N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • FBGL Miscellaneous manufacturing industries
  • Sector
  • CARM Health Care
  • FBGL Consumer Discretionary
  • Exchange
  • CARM Nasdaq
  • FBGL Nasdaq
  • Market Cap
  • CARM 12.1M
  • FBGL 10.5M
  • IPO Year
  • CARM N/A
  • FBGL 2025
  • Fundamental
  • Price
  • CARM $0.26
  • FBGL $0.72
  • Analyst Decision
  • CARM Hold
  • FBGL
  • Analyst Count
  • CARM 5
  • FBGL 0
  • Target Price
  • CARM $0.90
  • FBGL N/A
  • AVG Volume (30 Days)
  • CARM 1.1M
  • FBGL 714.7K
  • Earning Date
  • CARM 11-06-2025
  • FBGL 11-23-2025
  • Dividend Yield
  • CARM N/A
  • FBGL N/A
  • EPS Growth
  • CARM N/A
  • FBGL N/A
  • EPS
  • CARM N/A
  • FBGL N/A
  • Revenue
  • CARM $10,767,000.00
  • FBGL $10,146,582.00
  • Revenue This Year
  • CARM N/A
  • FBGL N/A
  • Revenue Next Year
  • CARM N/A
  • FBGL N/A
  • P/E Ratio
  • CARM N/A
  • FBGL N/A
  • Revenue Growth
  • CARM N/A
  • FBGL N/A
  • 52 Week Low
  • CARM $0.14
  • FBGL $0.44
  • 52 Week High
  • CARM $1.27
  • FBGL $5.45
  • Technical
  • Relative Strength Index (RSI)
  • CARM 44.09
  • FBGL 55.01
  • Support Level
  • CARM $0.24
  • FBGL $0.68
  • Resistance Level
  • CARM $0.27
  • FBGL $0.87
  • Average True Range (ATR)
  • CARM 0.03
  • FBGL 0.08
  • MACD
  • CARM -0.00
  • FBGL 0.00
  • Stochastic Oscillator
  • CARM 26.11
  • FBGL 43.71

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial, and industrial building projects. As a green contractor focused on environmentally sound practices, the company aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts and Sales of construction materials.

Share on Social Networks: